Curevac N.V. (NQ: CVAC )
5.490 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist
Press Releases about Curevac N.V.
CureVac Announces Voting Results of General Meeting
June 19, 2023
CureVac Announces Proposed Public Offering of Common Shares
February 07, 2023
CureVac Welcomes Myriam Mendila as New Chief Development Officer
February 01, 2023
CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
January 09, 2023
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / July 5, 2022 / CureVac N.V. (NASDAQ:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...